Editorial Nanobyte – Perspectives and milestones in molecular biology and immuno-oncology Radhika A. Vaishnav DOI:10.25259/IJMIO-1-2019 Full text | PDF p.1-2
Conference Review Leadership in immuno-oncology network 2 (LION:2) immunotherapy oncology – A present status Prashant Mehta, Vineet Talwar, Ankur Bahl DOI:10.25259/IJMIO-2-2019 Full text | PDF p.3-5
Original Article Special considerations for consent in immuno-oncology – Medic LAWgic recommendations Purvish M. Parikh, Karishma Jhaveri, Ankur Bahl, Vineet Talwar, Pritish Gandhi, Randeep Singh, Sudeep Shreshta, TP Sahoo DOI:10.25259/IJMIO-3-2019 Full text | PDF p.6-8
Original Article Oral cancers – Micronuclei as biomarker of genotoxicity a population-based study to establish usable dynamic cut off limits in tobacco users Suresh Amin, Nilam Patel, Bharat Chattoo DOI:10.25259/IJMIO-4-2019 Full text | PDF p.9-12
Original Article Multiple gene silencing in pathway in K562 cells Vinod Rajendran, Sudha S. Deo DOI:10.25259/IJMIO-5-2019 Full text | PDF p.13-20
Position Paper Practical consensus recommendations – Current role of immune response evaluation criteria in solid tumors criteria in the management of cancer patients receiving immunotherapy Purvish M. Parikh, T. P. Sahoo, Randeep Singh, Bahl Ankur, Talvar Vineet, G. S. Bhattacharyya, Babu Govind, Mehta Prashant DOI:10.25259/IJMIO-6-2019 Full text | PDF p.21-23
Case Report An unusual synchronous association of chronic myeloid leukemia with carcinoma tongue Sajal Goel, Deepak Kumar Mittal, Pankaj Sharma DOI:10.25259/IJMIO-7-2019 Full text | PDF p.24-26
Letter to Editor Artificial intelligence: A new era of technological advancement in oncology care Padmaj S. Kulkarni, Shruti S. Gandhi, Sachin S. Hingmire, Chetan D. Deshmukh DOI:10.25259/IJMIO-8-2019 Full text | PDF p.27-28
PDF 
